These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31945491)

  • 1. Clinicians' challenges in managing patients with invasive fungal diseases in seven Asian countries: An Asia Fungal Working Group (AFWG) Survey.
    Tan BH; Chakrabarti A; Patel A; Chua MMM; Sun PL; Liu Z; Rotjanapan P; Li R; Wahyuningsih R; Chayakulkeeree M; Chen YC;
    Int J Infect Dis; 2020 Jun; 95():471-480. PubMed ID: 31945491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: An Asia Fungal Working Group (AFWG) initiative.
    Chindamporn A; Chakrabarti A; Li R; Sun PL; Tan BH; Chua M; Wahyuningsih R; Patel A; Liu Z; Chen YC; Chayakulkeeree M
    Med Mycol; 2018 Jun; 56(4):416-425. PubMed ID: 29036605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM).
    Salmanton-García J; Au WY; Hoenigl M; Chai LYA; Badali H; Basher A; Brockhoff RA; Chen SC; Chindamporn A; Chowdhary A; Heath CH; Jabeen K; Lee J; Matar M; Taj-Aldeen SJ; Tan BH; Uno K; Wahyuningsih R; Zhu L; Chakrabarti A; Cornely OA
    Int J Antimicrob Agents; 2023 Mar; 61(3):106718. PubMed ID: 36640851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice.
    Schelenz S; Owens K; Guy R; Rautemaa-Richardson R; Manuel RJ; Richardson M; Moore C; Enoch DA; Micallef C; Howard P; Agrawal SG; Johnson EM; Muller-Pebody B;
    J Infect; 2019 Aug; 79(2):167-173. PubMed ID: 31233810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
    Lortholary O; Fernández-Ruiz M; Perfect JR
    J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ruhnke M; Cornely OA; Schmidt-Hieber M; Alakel N; Boell B; Buchheidt D; Christopeit M; Hasenkamp J; Heinz WJ; Hentrich M; Karthaus M; Koldehoff M; Maschmeyer G; Panse J; Penack O; Schleicher J; Teschner D; Ullmann AJ; Vehreschild M; von Lilienfeld-Toal M; Weissinger F; Schwartz S
    Mycoses; 2020 Jul; 63(7):653-682. PubMed ID: 32236989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training should be the first step toward an antifungal stewardship program.
    Valerio M; Muñoz P; Rodríguez-González C; Sanjurjo M; Guinea J; Bouza E;
    Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):221-7. PubMed ID: 25066382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving awareness, diagnosis and management of invasive fungal infections in Ghana: establishment of the Ghana Medical Mycology Society.
    Ocansey BK; Dadzie EA; Eduful SK; Agyei M; Osei MM; Puplampu P; Asamoah I; Oladele RO; Osaigbovo II; Afriyie-Mensah JS; Opintan JA; Essien-Baidoo S; Chakrabarti A; Hoenigl M; Denning DW; Richardson MD
    Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36073757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal use in children with acute leukaemia: state of current evidence and directions for future research.
    Yeoh DK; Haeusler GM; McMullan BJ; Butters C; Bryant PA; Clark JE; Cooper CM; Gwee A; Kotecha RS; Lai T; Slavin MA; Thursky KA; Blyth CC
    J Antimicrob Chemother; 2022 May; 77(6):1508-1524. PubMed ID: 35301533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentric Study on the Clinical Mycology Capacity and Access to Antifungal Treatment in Portugal.
    Fernandes R; Sabino R; Cunha C; Cornely OA; Carvalho A; Salmanton-García J;
    Mycopathologia; 2024 Jan; 189(1):15. PubMed ID: 38265528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers (the 6th revision)].
    ;
    Zhonghua Nei Ke Za Zhi; 2020 Oct; 59(10):754-763. PubMed ID: 32987477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Invasive Fungal Disease in Neonates and Children.
    Ferreras-Antolín L; Sharland M; Warris A
    Pediatr Infect Dis J; 2019 Jun; 38(6S Suppl 1):S2-S6. PubMed ID: 31205236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' knowledge of invasive fungal disease in China.
    Chen Y; Huang X; Qiu H; Cheng L; Yu Y; Ma X; Feng S; Li Q; Wu D; Huang W; Chen D; Lv X; Hu J; Wang J; Li J; Yang W; Zhan Q; Sun B; Wang M
    Mycoses; 2023 Aug; 66(8):723-731. PubMed ID: 37059587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey.
    Salmanton-García J; Hoenigl M; Gangneux JP; Segal E; Alastruey-Izquierdo A; Arikan Akdagli S; Lagrou K; Özenci V; Vena A; Cornely OA
    Lancet Microbe; 2023 Jan; 4(1):e47-e56. PubMed ID: 36463916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of Medical Mycology at German Academic Medical Centres: A Survey of the German-Speaking Mycological Society (DMYKG) and the Paul-Ehrlich-Society for Chemotherapy (PEG).
    Groll AH; Gordon K; Buchheidt D; Willinger B; Heinz WJ; Kurzai O; Rickerts V; Cornely OA;
    Mycoses; 2021 Oct; 64(10):1177-1182. PubMed ID: 34180098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of knowledge and experience of fungal infections (mycoses) among clinical doctors in Senegal.
    Diongue K; Dembélé B; Ndiaye M; Seck MC; Diallo MA; Badiane AS; Ndiaye D; Ranque S
    J Mycol Med; 2023 Aug; 33(3):101408. PubMed ID: 37307640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan.
    Kung HC; Huang PY; Chen WT; Ko BS; Chen YC; Chang SC; Chuang YC; ; ; ;
    J Microbiol Immunol Infect; 2018 Feb; 51(1):1-17. PubMed ID: 28781150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape.
    Vena A; Bassetti M; Mezzogori L; Marchesi F; Hoenigl M; Giacobbe DR; Corcione S; Bartoletti M; Stemler J; Pagano L; Cornely OA; Salmanton-García J
    Infection; 2024 Feb; 52(1):197-208. PubMed ID: 37656348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China.
    Xu XH; Zhang L; Cao XX; Li J; Zhang W; Zhu TN; Cai HC; Chen M; Han X; Yang C; Han B; Zhang Y; Zhuang JL; Zhou DB; Duan MH
    J Infect Chemother; 2017 Jun; 23(6):360-367. PubMed ID: 28341518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal stewardship in invasive Candida infections.
    Ruhnke M
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():11-8. PubMed ID: 24661820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.